Immunohistochemical study of epidermal growth factor receptor expression in esophageal squamous cell carcinoma

Arkhiv Patologii

Volumn 72, Issue 5, 2010, Pages 3-6

  Delektorskaya, V V ^a   Chemeris, G Yu ^a   Kononets, P V ^a   Grisor chuk, A Yu ^a  

^a NONE

Author keywords

EGFR; Esophageal cancer; HER 2; Immunohlstochemistry; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER INVASION; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 78650875662     PISSN: 00041955     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Akamatsu M., Matsumoto T., Oka K. et al. C-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma Int. J. Radiât. Oncol. Biol. Phys. -2003. - Vol. 57. - P. 1323-1327.
2. Dreilich M., Wanders A., Brattstròm D. et al. HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival Dis. Esophagus. - 2006. - Vol. 19, N 4. - P. 224231.
3. Gibault L., MetgesJ. P., Conan-Charlet V. et al. Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer Br. J. Cancer. -2005. -Vol. 93. -P. 107115.
4. Gockel I., Moehler M., Frerichs K. et al. Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer Oncol. Rep. -2008. - Vol. 20, N 4. - P. 845-850.
5. Gotoh M., Takiuchi H., Kawabe S. et al. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma Jpn. J. Clin. Oncol. - 2007. - Vol. 37, N 9. - P. 652-657.
6. Hanawa M., Suzuki S., Dobashi Y. et al. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus Int. J. Cancer. -2006. -Vol. 118.- P. 1173-1180.
7. Lehrbach D. M., Nita M. E., Cecconello I. Molecular aspects of esophageal squamous cell carcinoma carcinogenesis Arq. Gastroenterol. -2003. -Vol. 40, N 4. - P. 256-261.
8. Lin D. C, Du X. L., Wang M. R. Protein alterations in ESCC and clinical implications: a review Dis. Esophagus. - 2009. - Vol. 22, N 1. - P. 9-20.
9. Mimura K., Kono K., Hanawa M. et al. Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma Br. J. Cancer. - 2005. - Vol. 92. - P. 1253-1260.
10. Morgan S., Grandis J. R. ErbB receptors in the biology and pathology of the aerodigestive tract Exp. Cell Res. - 2009. - Vol. 315, N 4. - P. 572-582.
11. Reichelt U., Duesedau P., Tsourlakis M. et al. Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus Mod. Pathol. - 2007. - Vol. 20. - P. 120-129.
12. Rubin L, Yarden Y. The basic biology of HER2 Ann. Oncol. - 2001. - Vol. 12. - Suppl. 1. - P. S3-S8.
13. Sato-Kuwabara Y, Neves J. I., Fregnani J. H. et al. Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry BMC Cancer. - 2009. - Vol. 9. - P. 6.
14. Sunpaweravong P., SunpaweravongS., Puttawibul P. et al. Epidermal growth factor receptor and cyclin Dl are independently amplified and overexpressed in esophageal squamous cell carcinoma J. Cancer Res. Clin. Oncol. -2005.-Vol. 131.-P. 111-119.
15. Yarden Y., Sliwkowski M. X. Untangling the ErbB signalling network Nat. Rev. MoI. Cell Biol. -2001. - Vol. 2, N 2. - P. 127-137.
16. Yu D., Hung M. C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene. -2000. - Vol. 19, N 53.-P. 6115-6121.